Medical Devices Startups

Bloom Standard develops RAPIDscan, an autonomous, hands-free ultrasound system with AI-driven onboard image interpretation to detect cardiac and lung abnormalities in newborns, children, and maternal patients. The device targets maternity, primary care, and under-resourced or humanitarian health settings, enabling use by non-specialist operators and integration with existing health systems.

1 investor

Bloom Surgical develops surgical instruments and technology solutions for surgical teams in healthcare settings.

1 investor

Blossom provides contract manufacturing and supply chain services for the pharmaceutical and medical cannabis industries in Europe, specializing in narcotics handling, API manufacturing, and logistics for medical cannabis products.

1 investor

Blue Cell Therapeutics develops an off-the-shelf allogeneic stem cell therapy platform (Blue Cells) that promotes angiogenesis and nerve repair, with a lead candidate (BlueC-231) aimed at treating severe erectile dysfunction in men after radical prostatectomy. The company operates in the biotech and cell therapy space, targeting patients unresponsive to existing drug treatments.

1 investor

Blue Rabbit is an online veterinary pharmacy that integrates with practice management software to automate prescription fulfillment and patient data management. It offers a broad formulary of compounded medications, pharmaceuticals, and veterinary products with streamlined ordering and shipping for veterinary practices.

1 investor

Blue Spark Technologies manufactures wearable medical devices for continuous patient monitoring in healthcare settings. The company designs and distributes temperature and vital sign tracking devices used by hospitals and clinical providers for earlier medical intervention.

1 investor

Bluedrop Medical develops a medical device that allows people with diabetes to scan their feet for early detection of foot ulcers through temperature data and imaging analysis. The company aims to prevent diabetic amputations by enabling early intervention in at-risk patients.

1 investor

Bluegrass Vascular develops medical devices for restoring venous access in chronically occluded veins using an inside-out catheter approach. The company serves clinical practitioners requiring advanced vascular intervention solutions.

1 investor

Blue Rock Therapeutics discovers and develops cell therapies to treat disease and improve patient outcomes. The company operates at the frontier of cell therapy science with a focus on innovation and patient impact.

1 investor

BLUEWAVE manufactures an FDA Class II medical device for at-home disinfection of orthotic and prosthetic devices using proprietary vacuum-infusion technology, designed to reduce bacterial contamination and infection risk in patients with diabetes, limb loss, or immune deficiency.

1 investor

BlueWhale Bio develops manufacturing technologies for cell-based therapies, focusing on cell activation and expansion in early-stage processing to improve efficiency and reduce costs. The company serves medical institutions and therapeutics developers working with cell therapy products.

1 investor

BlueWillow Biologics develops an intranasal vaccine delivery platform using novel oil-in-water emulsion technology to address pandemic preparedness, infectious diseases, and food allergies. The company is a clinical-stage biotech firm with proprietary technology originally discovered at the University of Michigan.

1 investor

Bluue Co. develops AI models and data-collection hardware devices for cardiology and maternity care. The company aims to make high-quality cardiac and maternal care accessible regardless of location or wealth, working with NGOs and research institutions.

1 investor

BMI OrganBank develops organ perfusion and preservation systems to improve transplantation outcomes and extend organ viability outside the body. The company serves transplant clinicians and researchers working to reduce organ transplant waitlists and advance regenerative medicine.

1 investor

Boca Bio provides biospecimen sourcing for life sciences research through its BioSpecimen360 offering. It serves researchers who need access to biological specimens.

1 investor

Bolt Medical develops the Bolt IVL intravascular lithotripsy system, a laser-based balloon catheter platform that fractures arterial calcium using acoustic pressure waves to treat coronary and peripheral artery disease. The medical device company, founded in 2019, serves interventional cardiologists and their patients with calcified arterial lesions.

1 investor

Bondent manufactures a dental CBCT imaging system with multiple imaging modes (CBCT, panoramic, cephalometric, and periapical) designed for dental clinics. The system incorporates artifact correction technology and AI-assisted tools for orthodontic planning and treatment communication.

1 investor

Bonray Bio develops miniaturized microscopy optics and AI-powered image analysis software for reproductive medicine diagnostics, providing male infertility diagnostic instruments and consumables to fertility clinics globally.

1 investor

Bonus Biogroup is a clinical-stage biotechnology company developing tissue engineering and cell therapy products for unmet medical needs related to tissue damage, inflammation, and immune response. Its investigational products include MesenCure, an allogeneic cell therapy targeting inflammation, and BonoFill, a tissue-engineered bone graft for orthopedic and maxillofacial bone defects.

1 investor

Bookimed operates an online platform that connects patients with hospitals and clinics abroad for medical treatment, coordinating requests and matching people to healthcare providers. It functions as a medical tourism marketplace serving patients seeking care internationally.

1 investor

Borea Therapeutics develops gene therapy delivery technologies based on a proprietary AAV conjugation platform targeting neurological and genetic diseases. The company serves the therapeutic biotechnology market with precision neuronal targeting and advanced delivery strategies.

1 investor

Boston Bio Motion offers a patented platform for assessing movement and providing resistance training. The system tests full-body power, strength, and speed, tracks progress, generates personalized training reports, and supports 3D resistance training and rehabilitation.

1 investor

Boston Cell Standards develops calibration and quality-control products (IHCalibrators and IHControls) for immunohistochemistry (IHC) laboratories, used for assay validation, instrument alignment, troubleshooting, and proficiency testing. Its standards serve clinical and research labs and drug developers to maintain consistent IHC test results across sites and trial phases for accurate patient diagnosis and treatment stratification.

1 investor

Boston Micromachines manufactures deformable mirrors and intensity modulation components based on MEMS technology for research and optical applications. The company offers both standard products and custom technology development services.

1 investor